BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112089
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112089
Table 1 General patient information
Item
Category
Number of cases
Percentage
Basic characteristics
SexMale3264%
Female1836%
Family historyYes1632%
Behavioral risk factorsSmoking510%
Alcohol consumption510%
Tumor characteristics
Primary siteStomach1530%
Intestine3570%
Maximum tumor diameter> 5 cm2346%
≤ 5 cm1632%
Infiltrative growth difficult to evaluate1122%
Clinical manifestations
Initial symptomAbdominal pain2652%
Abdominal mass816%
Mass with pain24%
Hematochezia or melena714%
Others714%
Concurrent symptomsPain4080%
Hematochezia/melena1938%
Nausea and vomiting1632%
Weight loss1836%
Anemia1938%
ComorbiditiesCardiac disease816%
Chest disease2040%
Gastritis1326%
Liver disease1734%
Gallbladder disease816%
Other abdominal diseases2856%
Central nervous system disease510%
Hypertension1020%
Diabetes714%
Metastasis to other sites3060%
Table 2 Auxiliary examination results
Characteristics
Number of examinations
Positive diagnoses
Percentage
Ultrasound491836.7%
CT353394.3%
PET-CT362466.7%
Endoscopy474391.5%
Table 3 Staging and risk
Characteristics
Classification
Number of cases
Percentage
Lugano stageI1020%
II2244%
III612%
IV1224%
IPI riskLow2958%
Low-intermediate1020%
High-intermediate918%
High24%
Table 4 Treatment outcomes
Characteristics
Classification
Number of cases
Percentage
Surgery groupImprovement940.9%
Stable522.7%
Deterioration836.3%
Non-surgery groupImprovement425.0%
Stable637.5%
Deterioration637.5%